Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study
暂无分享，去创建一个
T. Kanai | Mamoru Watanabe | T. Takehara | T. Naka | M. Matsuura | N. Yoshimura | T. Torisu | A. Shiotani | Hiroki Tanaka | Kenji Watanabe | S. Kato | H. Iijima | K. Matsuoka | S. Mizuno | F. Hirai | S. Hiraoka | F. Takeshima | Taku Kobayashi | Y. Ohta | S. Shinzaki | Shiro Nakamura | T. Matsumoto | Shohei Nishimoto | Yuki Ohta | Fumihito Hirai